Cancer / Oncology
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark f...
February 25, 2022 | News
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China
JAB-21822 in combination with cetuximab for the treatment of KRAS G12C-mutated advanced colorectal cancer. Colorectal cancer is the second most common tumo...
February 24, 2022 | News
Patients can now benefit from same-day procedure to diagnose and treat lung cancer
Imagine being diagnosed with lung cancer and having the tumor surgically removed on the same day, thereby increasing the opportunity for limited follow-up ...
February 22, 2022 | News
First Proton Therapy Treatment Delivered in Southeast Asia
The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...
February 09, 2022 | News
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology
Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...
February 04, 2022 | News
Reaction Biology Announces Integrated Drug Discovery Solution
The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...
February 03, 2022 | News
BioMed X Institute and Merck KGaA, Extend Collaboration in Oncology
German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the res...
February 01, 2022 | News
Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...
February 01, 2022 | News
Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...
January 25, 2022 | News
Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer
Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...
January 24, 2022 | News
Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan
Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...
January 04, 2022 | News
First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...
December 29, 2021 | News
Regor Therapeutics announced authorization from the USFDA to proceed with Regor's Phase 1 clinical development plans for RGT-419B.
On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration ...
December 28, 2021 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
